Apar Kishor Ganti
University of Nebraska Medical Center
H-index: 49
North America-United States
Top articles of Apar Kishor Ganti
A cross-sectional survey of patient attitudes towards telemedicine in head and neck surgical oncology
American Journal of Otolaryngology
2024/4/24
Abstract CT268: Palbociclib (P) in patients (pts) with solid tumors with CCND1 amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling …
Cancer Research
2024/4/5
Apar Kishor Ganti
H-Index: 30
Quality of Life and Depression Symptoms After Therapy De-Escalation in HPV+ Oropharyngeal Squamous Cell Carcinoma: A Nonrandomized Controlled Trial
JAMA Otolaryngology–Head & Neck Surgery
2024/4/4
Comparison of Induction Cisplatin, Docetaxel, and 5-Fluorouracil to An Induction Platinum Doublet Regimen for Locally Advanced Human Papillomavirus-Associated Oropharyngeal Cancer
International Journal of Radiation Oncology, Biology, Physics
2024/4/1
Disparities in Thyroid Cancer Diagnosis based on Residence and Distance from Medical Facility
Journal of the Endocrine Society
2024/2/18
Anupam Kotwal
H-Index: 11
Apar Kishor Ganti
H-Index: 30
Durvalumab Outcomes in Stage III Non-small Cell Lung Cancer: A Single-institution Study
Anticancer Research
2024/2/1
Local Clinical Trials: The Need of the Hour to Improve Global Cancer Care
Indian Journal of Medical and Paediatric Oncology
2024/2
Apar Kishor Ganti
H-Index: 30
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on …
Clinical Cancer Research
2024/1/5
Wei Wei
H-Index: 5
Apar Kishor Ganti
H-Index: 30
Phase I/II study to evaluate consolidative hypofractionated radiation therapy for boosting the residual primary disease in combination with durvalumab after definitive …
Journal of Thoracic Disease
2024/1/1
EE152 Cost-effectiveness modeling of lurbinectedin as a second-line therapy in patients with small cell lung cancer (SCLC)
Value in Health
2023/6/1
The prognostic value of patient reported outcomes (PROs) and clinical/demographic variables in the CASPIAN study.
Journal of Clinical Oncology
2019/5/20
Abstract A003: COVALENT-102: A phase 1/1b dose finding study of BMF-219, an oral covalent menin inhibitor, in patients with metastatic non-small cell lung cancer (NSCLC …
Molecular Cancer Research
2023/5/1
FOXM1 inhibition: A novel therapeutic approach for small cell lung cancer
Cancer Research
2023/4/4
MUC5AC promotes brain metastases and colonization in non small cell lung cancer
Cancer Research
2023/4/4
Sanjib Chaudhary
H-Index: 9
Jawed Siddiqui
H-Index: 17
Imayavaramban Lakshmanan
H-Index: 21
Apar Kishor Ganti
H-Index: 30
MicroRNA-1 run down the growth and metastasis of small cell lung cancer
Cancer Research
2023/4/4
Sanjib Chaudhary
H-Index: 9
Imayavaramban Lakshmanan
H-Index: 21
Apar Kishor Ganti
H-Index: 30
Maneesh Jain
H-Index: 33
Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients
International Journal of Clinical Oncology
2023/4
Apar Kishor Ganti
H-Index: 30
Michael Kelley
H-Index: 2
MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR
Breast Cancer Research
2023/3/14
Mucins as potential biomarkers for early detection of cancer
2023/3/7
PP01. 76 Lurbinectedin vs an External Control arm in Patients with Small Cell Lung Cancer
Journal of Thoracic Oncology
2023/3/1
Elevated PAF1-RAD52 axis confers chemoresistance to human cancers
Cell reports
2023/2/28
